Connection

Stephen Ethier to Animals

This is a "connection" page, showing publications Stephen Ethier has written about Animals.
Connection Strength

0.413
  1. Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
    View in: PubMed
    Score: 0.051
  2. Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3. Breast Cancer Res Treat. 2017 Jul; 164(2):349-358.
    View in: PubMed
    Score: 0.043
  3. Amphiregulin as a novel target for breast cancer therapy. J Mammary Gland Biol Neoplasia. 2008 Jun; 13(2):171-9.
    View in: PubMed
    Score: 0.023
  4. Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways. Int J Cancer. 2007 Sep 15; 121(6):1265-73.
    View in: PubMed
    Score: 0.022
  5. Epidermal growth factor receptor signaling and response of cancer cells to ionizing radiation. J Natl Cancer Inst. 2001 Jun 20; 93(12):890-1.
    View in: PubMed
    Score: 0.014
  6. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence. Endocrinology. 1999 Aug; 140(8):3615-22.
    View in: PubMed
    Score: 0.012
  7. Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models. BMC Cancer. 2018 Dec 10; 18(1):1233.
    View in: PubMed
    Score: 0.012
  8. ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen. Vaccine. 2018 10 08; 36(42):6262-6269.
    View in: PubMed
    Score: 0.012
  9. MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer. Cancer Res. 2017 12 01; 77(23):6641-6650.
    View in: PubMed
    Score: 0.011
  10. Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. Nat Commun. 2016 10 11; 7:13050.
    View in: PubMed
    Score: 0.010
  11. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Mol Carcinog. 1996 Feb; 15(2):134-43.
    View in: PubMed
    Score: 0.010
  12. Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression. Oncogene. 2016 08 04; 35(31):4036-47.
    View in: PubMed
    Score: 0.010
  13. The culture of cell culture practices and authentication--Results from a 2015 Survey. Biotechniques. 2015 Oct; 59(4):189-90, 192.
    View in: PubMed
    Score: 0.010
  14. Reproducibility: changing the policies and culture of cell line authentication. Nat Methods. 2015 Jun; 12(6):493-7.
    View in: PubMed
    Score: 0.009
  15. Insulin like growth factor-I independence in rat mammary carcinoma cells: a dominant phenotype in somatic cell hybrid experiments. Cancer Lett. 1993 Nov 01; 74(3):189-95.
    View in: PubMed
    Score: 0.008
  16. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 2013 Oct 14; 24(4):450-65.
    View in: PubMed
    Score: 0.008
  17. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology. 1992 Jun; 183(3):643-7.
    View in: PubMed
    Score: 0.008
  18. Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA. Int J Cancer. 2012 Dec 01; 131(11):2562-72.
    View in: PubMed
    Score: 0.008
  19. Secretion of an epidermal growth factor-like growth factor by epidermal growth factor-independent rat mammary carcinoma cells. Cell Growth Differ. 1991 Nov; 2(11):593-602.
    View in: PubMed
    Score: 0.007
  20. Multiple growth factor independence in rat mammary carcinoma cells. Breast Cancer Res Treat. 1991 May; 18(2):73-81.
    View in: PubMed
    Score: 0.007
  21. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 2011 Feb 15; 71(4):1292-301.
    View in: PubMed
    Score: 0.007
  22. The role of Ha-ras oncogenes in growth factor independence in rat mammary carcinoma cells. Mol Carcinog. 1991; 4(4):286-96.
    View in: PubMed
    Score: 0.007
  23. Role of growth factor synthesis in the acquisition of insulin/insulin-like growth factor I independence in rat mammary carcinoma cells. Cancer Res. 1990 Sep 01; 50(17):5351-7.
    View in: PubMed
    Score: 0.007
  24. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo. Cancer Res. 2010 May 15; 70(10):3996-4004.
    View in: PubMed
    Score: 0.007
  25. Secretion of a TGF-beta-like growth inhibitor by normal rat mammary epithelial cells in vitro. J Cell Physiol. 1990 Jan; 142(1):15-20.
    View in: PubMed
    Score: 0.006
  26. cAMP levels in proliferating rat mammary epithelial cells in vitro and in vivo. Exp Cell Res. 1989 Jun; 182(2):653-8.
    View in: PubMed
    Score: 0.006
  27. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet. 2008 Jan; 40(1):102-7.
    View in: PubMed
    Score: 0.006
  28. Importance of extended growth potential and growth factor independence on in vivo neoplastic potential of primary rat mammary carcinoma cells. Cancer Res. 1987 Oct 15; 47(20):5316-22.
    View in: PubMed
    Score: 0.006
  29. Influence of hormone and growth factor interactions on the proliferative potential of normal rat mammary epithelial cells in vitro. J Cell Physiol. 1987 Jul; 132(1):161-7.
    View in: PubMed
    Score: 0.005
  30. Serum-free culture conditions for the growth of normal rat mammary epithelial cells in primary culture. In Vitro Cell Dev Biol. 1986 Aug; 22(8):485-90.
    View in: PubMed
    Score: 0.005
  31. Primary culture and serial passage of normal and carcinogen-treated rat mammary epithelial cells in vitro. J Natl Cancer Inst. 1985 Jun; 74(6):1307-18.
    View in: PubMed
    Score: 0.005
  32. Morphological and histological characteristics of mammary dysplasias occurring in cell dissociation-derived murine mammary outgrowths. Cancer Res. 1984 Oct; 44(10):4517-22.
    View in: PubMed
    Score: 0.004
  33. Factors influencing expression of mammary ductal dysplasia in cell dissociation-derived murine mammary outgrowths. Cancer Res. 1984 Oct; 44(10):4523-7.
    View in: PubMed
    Score: 0.004
  34. Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo. Clin Cancer Res. 2004 Jan 15; 10(2):691-700.
    View in: PubMed
    Score: 0.004
  35. Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice. Cancer Res. 1982 May; 42(5):1753-60.
    View in: PubMed
    Score: 0.004
  36. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 2001 Jul 01; 61(13):5168-78.
    View in: PubMed
    Score: 0.004
  37. The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Invest. 2000 Jun; 105(11):1537-45.
    View in: PubMed
    Score: 0.003
  38. A bcl-xS adenovirus selectively induces apoptosis in transformed cells compared to normal mammary cells. Neoplasia. 2000 May-Jun; 2(3):251-60.
    View in: PubMed
    Score: 0.003
  39. SUM-159PT cells: a novel estrogen independent human breast cancer model system. Breast Cancer Res Treat. 1999 Dec; 58(3):193-204.
    View in: PubMed
    Score: 0.003
  40. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res. 1999 Sep; 5(9):2511-9.
    View in: PubMed
    Score: 0.003
  41. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 1997 Dec; 8(12):1267-76.
    View in: PubMed
    Score: 0.003
  42. Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen. Cancer Res. 1996 Sep 01; 56(17):4049-55.
    View in: PubMed
    Score: 0.003
  43. Biological disposition and imaging of a radioiodinated alkylphosphocholine in two rodent models of breast cancer. J Nucl Med. 1996 Sep; 37(9):1540-5.
    View in: PubMed
    Score: 0.003
  44. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nucl Med. 1996 Jun; 37(6):1042-7.
    View in: PubMed
    Score: 0.003
  45. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med. 1995 Oct; 36(10):1854-61.
    View in: PubMed
    Score: 0.002
  46. Fluorine-18-fluorodeoxyglucose-guided breast cancer surgery with a positron-sensitive probe: validation in preclinical studies. J Nucl Med. 1995 Oct; 36(10):1869-74.
    View in: PubMed
    Score: 0.002
  47. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. J Nucl Med. 1990 Nov; 31(11):1831-5.
    View in: PubMed
    Score: 0.002
  48. Enhanced in vitro proliferation and in vivo tumorigenic potential of mammary epithelium from BALB/c mice exposed in vivo to gamma-radiation and/or 7,12-dimethylbenz[a]anthracene. Cancer Res. 1987 Aug 15; 47(16):4425-31.
    View in: PubMed
    Score: 0.001
  49. Survival of mammary epithelial cells from virgin female BALB/c mice following in vivo gamma irradiation. Radiat Res. 1984 Nov; 100(2):264-72.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.